Stock NRO NEURONES
Add to a list
To use this feature you must be a member
Log inSign up

Financials NEURONES

Equities

NRO

FR0004050250

IT Services & Consulting

Market Closed - Euronext Paris
Other stock markets
 11:35:18 2024-05-31 am EDT 		5-day change 1st Jan Change
47.4 EUR +0.53% Intraday chart for NEURONES +0.85% +8.34%
May. 29 Neurones: Invesco Ltd falls below 5% of share capital CF
May. 15 Neurones: 9.5% sales growth in Q1 CF

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 500.3 566.7 920.3 950.8 1,062 1,151
Enterprise Value (EV) 1 282 334 655.7 679 1,062 856.5
P/E ratio 16.2 x 18.4 x 24.5 x 21.6 x 21.6 x 21.1 x
Yield 0.97% 0.85% 2.63% 2.55% - 2.53%
Capitalization / Revenue 0.98 x 1.08 x 1.59 x 1.43 x 1.43 x 1.45 x
EV / Revenue 0.55 x 0.64 x 1.13 x 1.02 x 1.43 x 1.08 x
EV / EBITDA 4.56 x 5.57 x 8.6 x 7.59 x 11.5 x 8.75 x
EV / FCF 5,999,761 x 5,557,774 x 12,917,098 x 15,306,020 x 20,579,785 x -
FCF Yield 0% 0% 0% 0% 0% -
Price to Book 1.68 x 1.76 x 2.95 x 2.87 x - 3.01 x
Nbr of stocks (in thousands) 24,286 24,218 24,218 24,224 24,272 24,274
Reference price 2 20.60 23.40 38.00 39.25 43.75 47.40
Announcement Date 3/4/20 2/10/21 2/9/22 2/8/23 3/6/24 -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 510.1 524.5 579.9 665.4 741.2 793.1
EBITDA 1 61.79 60 76.28 89.44 92.61 97.91
EBIT 1 53.7 51.9 61.6 72.9 75.9 79.39
Operating Margin 10.53% 9.9% 10.62% 10.96% 10.24% 10.01%
Earnings before Tax (EBT) 53.8 53.6 61.7 72.86 80.76 -
Net income 1 30.8 30.9 37.7 44.3 49.4 54.57
Net margin 6.04% 5.89% 6.5% 6.66% 6.66% 6.88%
EPS 2 1.270 1.270 1.550 1.820 2.030 2.247
Free Cash Flow 47 60.1 50.76 44.36 51.6 -
FCF margin 9.21% 11.46% 8.75% 6.67% 6.96% -
FCF Conversion (EBITDA) 76.06% 100.16% 66.55% 49.6% 55.72% -
FCF Conversion (Net income) 152.6% 194.49% 134.65% 100.14% 104.45% -
Dividend per Share 2 0.2000 0.2000 1.000 1.000 - 1.200
Announcement Date 3/4/20 2/10/21 2/9/22 2/8/23 3/6/24 -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - - -
Net Cash position 1 218 233 265 272 - 294
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 47 60.1 50.8 44.4 51.6 -
ROE (net income / shareholders' equity) 11.4% 9.97% 11.9% 13.8% - 14.8%
ROA (Net income/ Total Assets) - - - 7.47% - -
Assets 1 - - - 593.3 - -
Book Value Per Share 2 12.20 13.30 12.90 13.70 - 15.80
Cash Flow per Share 2 2.520 2.770 2.360 2.660 - 3.050
Capex 7.89 - - 10.6 - -
Capex / Sales 1.55% - - 1.59% - -
Announcement Date 3/4/20 2/10/21 2/9/22 2/8/23 3/6/24 -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for NEURONES

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
47.4 EUR
Average target price
50 EUR
Spread / Average Target
+5.49%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other IT Services & Consulting

1st Jan change Capi.
NEURONES Stock NEURONES
+8.34% 1.25B
ACCENTURE PLC Stock Accenture plc
-19.53% 177B
TATA CONSULTANCY SERVICES LTD. Stock Tata Consultancy Services Ltd.
-3.23% 159B
IBM Stock IBM
+2.05% 153B
AUTOMATIC DATA PROCESSING, INC. Stock Automatic Data Processing, Inc.
+5.13% 100B
RELX PLC Stock RELX PLC
+9.84% 81.11B
CROWDSTRIKE HOLDINGS, INC. Stock CrowdStrike Holdings, Inc.
+22.85% 75.87B
INFOSYS LIMITED Stock Infosys Limited
-8.81% 69.81B
SNOWFLAKE INC. Stock Snowflake Inc.
-31.57% 45.63B
HCL TECHNOLOGIES LIMITED Stock HCL Technologies Limited
-9.69% 42.96B
Other IT Services & Consulting
  1. Stock Market
  2. Equities
  3. NRO Stock
  4. Financials NEURONES